» Articles » PMID: 1518850

Alloalbuminemia in Sweden: Structural Study and Phenotypic Distribution of Nine Albumin Variants

Overview
Specialty Science
Date 1992 Sep 1
PMID 1518850
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Plasma samples exhibiting alloalbuminemia on electrophoresis at pH 8.6 were requested from clinical laboratories throughout Sweden. Nine variants, each representing a different single point mutation, were found in 100 apparently unrelated Swedes. The overall prevalence of alloalbuminemia was estimated at 1:1700. Mutations were identified by protein-structural analysis followed by allele-specific DNA hybridization to verify the most common types. Slightly retarded (+1) mobility was seen in 80 cases. Of these, 71 had the Arg(-2)----Cys proalbumin variant previously called Malmö I proalbumin. Thirteen examples of the second most frequent type, the substitution Lys313----Asn and a mobility change of -1 charge unit, were found, as well as six cases of Glu570----Lys (albumin B) and a single case of Arg-1----Gln (proalbumin Christchurch). Five previously unreported types of alloalbuminemia were identified: four instances of Glu376----Gln, which is the second known mutation at this site; two examples of Asp550----Ala, the second mutation reported at this site; and one example each of Asp63----Asn, Gln268----Arg, and Asn318----Lys. Other mutations were identified among eight subjects of foreign descent. The high frequency and relatively uniform geographic distribution of the Arg-2----Cys mutation suggest that it may have occurred in a founder individual many generation ago in Sweden.

Citing Articles

Incidental detection of hereditary bisalbuminemia in a patient with positive DAT coombs: A case-based review.

Avgoustou E, Kounatidis D, Vallianou N, Karampela I, Stratigou T, Dalamaga M Metabol Open. 2024; 23:100307.

PMID: 39185032 PMC: 11342109. DOI: 10.1016/j.metop.2024.100307.


Mouse Type-I Interferon-Mannosylated Albumin Fusion Protein for the Treatment of Chronic Hepatitis.

Minayoshi Y, Maeda H, Hamasaki K, Nagasaki T, Takano M, Fukuda R Pharmaceuticals (Basel). 2024; 17(2).

PMID: 38399475 PMC: 10893114. DOI: 10.3390/ph17020260.


Human serum albumin variants in China: a molecular epidemiological investigation and literature review.

Wu J, Lin M, Lin F, Zhan X, Wang J, Yang H J Int Med Res. 2021; 49(12):3000605211064225.

PMID: 34919010 PMC: 8829792. DOI: 10.1177/03000605211064225.


Immune Dysfunction and Albumin-Related Immunity in Liver Cirrhosis.

Wilde B, Katsounas A Mediators Inflamm. 2019; 2019:7537649.

PMID: 30930689 PMC: 6410448. DOI: 10.1155/2019/7537649.


Determination of true ratios of different N-glycan structures in electrospray ionization mass spectrometry.

Grunwald-Gruber C, Thader A, Maresch D, Dalik T, Altmann F Anal Bioanal Chem. 2017; 409(10):2519-2530.

PMID: 28271226 PMC: 5359385. DOI: 10.1007/s00216-017-0235-8.


References
1.
Brennan S, Herbert P . Albumin Canterbury (313 Lys----Asn). A point mutation in the second domain of serum albumin. Biochim Biophys Acta. 1987; 912(2):191-7. DOI: 10.1016/0167-4838(87)90088-4. View

2.
Takahashi N, Takahashi Y, Isobe T, Putnam F, Fujita M, SATOH C . Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations. Proc Natl Acad Sci U S A. 1987; 84(22):8001-5. PMC: 299464. DOI: 10.1073/pnas.84.22.8001. View

3.
Neel J . Rare variants, private polymorphisms, and locus heterozygosity in Amerindian populations. Am J Hum Genet. 1978; 30(5):465-90. PMC: 1685597. View

4.
Sakamoto Y, Davis E, Madison J, Watkins S, McLaughlin H, Leahy D . Purification and structural study of two albumin variants in an Irish population. Clin Chim Acta. 1991; 204(1-3):179-87. DOI: 10.1016/0009-8981(91)90229-6. View

5.
Watkins S, Madison J, Davis E, Sakamoto Y, Galliano M, Minchiotti L . A donor splice mutation and a single-base deletion produce two carboxyl-terminal variants of human serum albumin. Proc Natl Acad Sci U S A. 1991; 88(14):5959-63. PMC: 52001. DOI: 10.1073/pnas.88.14.5959. View